Fiala

Peptide library › Longevity & cellular health

Elamipretide

Also known as SS-31, Forzinity, Bendavia

FDA-approved drugLongevity & cellular health

Mitochondria-targeting peptide approved for the rare genetic disorder Barth syndrome.

What people use it for

What Elamipretide does in the body

A small peptide that travels to the inner membrane of mitochondria, the cell's power plants, and binds cardiolipin, a fat that holds the energy-producing machinery together. This is thought to stabilise that machinery, improve energy production and reduce oxidative stress.

Strength of evidence

Moderate for Barth syndrome (approved on surrogate endpoints); mixed results in other mitochondrial and heart conditions.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved (accelerated approval) as Forzinity for Barth syndrome. Other uses are not approved.

How it's taken

Route: Injection under the skin once daily

How long it lasts (half-life): A few hours

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Elamipretide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Elamipretide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Longevity & cellular health